Singer Arlindo Cruz treated sequelae of strokes with cannabidiol oil; prescription and use conflict with the CFM ordinance
Even if it is a method that clashes with the determinations of the Federal Council of Medicine and with prejudice, as it is derived from the marijuana plant, the benefits of using the cannabidiol oil (CBD) are already attracting the attention of medical specialists and patients with neurological diseases. Research has already demonstrated the substance’s efficacy in delaying neurological sequelae and, many times, it becomes the last hope for patients and family members with this condition.
Last week, for example, the singer’s wife Arlindo CruzThe 64-year-old revealed that the singer is being treated at home with a cannabidiol oil treatment, to combat the aftermath of the cerebral vascular accident (CVA) he suffered in 2017. using cannabidiol oil is not the same as using the plant recreationallyi.e. smoke.
“The treatment is already showing significant results in physical and cognitive aspects. This is just the beginning, poet. We are very hopeful,” wrote his wife, Babi Cruz, in an Instagram post.
The case of Arlindo Cruz is not an isolated one. According to the National Health Surveillance Agency (Anvisa), more than 100,000 patients use marijuana extracts imported from abroad on prescription🇧🇷 Data shows that the number of patients importing cannabis products has increased approximately 15 times over the past five years.
What explains the efficacy of the medicinal use of cannabidiol
the biotechnologist Gabriel Barbosawho is a research and development supervisor at HempMeds, explains a Land that the interaction of cannabidiol with neurological receptors is crucial for the efficacy of the substance. The effect on seizures associated with some specific syndromes has already been demonstrated.
Among the diseases that may have treated sequelae, or reduced progress, are epilepsy, schizophrenia, Parkinson’s disease, and fibromyalgia. Cannabidiol oil is also effective in relieving and reducing stress and anxiety, among other mental health issues.
This happens mainly because this substance has the same benefits as antidepressants and anxiolytics, for example, but with fewer side effects.
“Its pharmacological interactions with receptors are essential for the proper functioning of our body,” Barbosa reiterates.
As explained Renato Anghina, a specialist in clinical neurophysiology, there is no absolute contraindication to the use of the substance. He also recalls that since 2018 cannabidiol is no longer a substance considered doping by the World Anti-Doping Agency (WADA). Athletes use the oil for muscle and joint pain, anxiety, nervous tension and insomnia.
In clinical treatment, the indication tends to be for neurological conditions.
“The substance is mainly indicated for patients with epilepsy who have not responded to conventional treatments and also for people on the autism spectrum in some countries,” he adds.
Cannabidiol oil legislation
Cannabidiol oil is made from a substrate taken from the cannabis plant, the same as marijuana, and requires specific care for planting, pruning and harvesting. Even the extraction itself has its quirks, such as the aid of an essential oil infuser and extraction equipment.
In Brazil, judicial authorization is required to plant cannabis, which must have a purely medicinal purpose.
Although research has shown the benefits of cannabidiol oil for other diseases, the Federal Council of Medicine (CFM) has further limited the prescription of the substance to only two types of epilepsy and tuberous sclerosis. The CFM has also banned lectures by doctors on the subject outside the scientific environment.
With the regulation just published, the Council authorizes the category of doctors to prescribe the product only for the treatment of epilepsy in children and adolescents associated with the Dravet and Lennox-Gastaut syndromes and Tuberous Sclerosis Complex. In the latter case, only in patients who have not shown good results with conventional treatments.
The October resolution highlights that doctors are prohibited from prescribing cannabidiol for therapeutic indications other than those envisaged by the new standard, with the exception of clinical trials approved in the country. In the previous resolution, from 2014, the Giunta gave a more general approach to the matter: it authorized the compassionate use of the substance for epilepsy in childhood and adolescence refractory to conventional therapies, without, therefore, limiting its use to a few pathologies.
🇧🇷The best content in your email for free. Choose your favorite Terra newsletter. Click here!
Source: Terra

Camila Luna is a writer at Gossipify, where she covers the latest movies and television series. With a passion for all things entertainment, Camila brings her unique perspective to her writing and offers readers an inside look at the industry. Camila is a graduate from the University of California, Los Angeles (UCLA) with a degree in English and is also a avid movie watcher.